Privacy Regulators Sample Clauses

Privacy Regulators. Provider shall provide, in a timely manner, all necessary and reasonable information and co-operation to Dell and to any regulatory or other governmental bodies or authorities with jurisdiction or oversight over Applicable Privacy Laws (each, a “Privacy Regulator”) in connection with any investigations, audits or inquiries made by any such Privacy Regulator under such legislation. Provider acknowledges that Dell may be required to disclose confidential information of Provider, without Provider’s consent, to such Privacy Regulators in connection with any investigation, audit or inquiry that pertains to or involves the Services.
AutoNDA by SimpleDocs
Privacy Regulators. (1) The Service Provider shall provide, in a timely manner, all necessary and reasonable information and co-operation to the CCAC and to any regulatory or other governmental bodies or authorities with jurisdiction or oversight over applicable privacy laws (each, a “Privacy Regulator”) in connection with any investigations, audits or inquiries made by any Privacy Regulator under Applicable Law. The Service Provider acknowledges that the CCAC may be required to disclose Confidential Information of the Service Provider (including, this Agreement and any agreement or other documentation relating to the Services), without the Service Provider’s consent, to such Privacy Regulators in connection with any investigation, audit or inquiry that pertains to or involves the Services.
Privacy Regulators. Service Provider shall provide, in a timely manner, all necessary and reasonable information and co-operation to Customer and to any regulatory or other governmental bodies or authorities with jurisdiction or oversight over Applicable Privacy Laws (each, a “Privacy Regulator”) in connection with any investigations, audits or inquiries made by any such Privacy Regulator under such legislation. Service Provider acknowledges that Customer may be required to disclose confidential information of Service Provider (including, without limitation, this Agreement and any agreement or other documentation relating to the Services), without Service Provider’s consent, to such Privacy Regulators in connection with any investigation, audit or inquiry that pertains to or involves the Services.
Privacy Regulators. (1) The Provider shall provide, in a timely manner, all necessary and reasonable information and co-operation to the LHIN and to any regulatory or other governmental bodies or authorities with jurisdiction or oversight over applicable privacy laws (each, a “Privacy Regulator”) in connection with any investigations, audits or inquiries made by any such Privacy Regulator under such legislation. The Provider acknowledges that the LHIN may be required to disclose confidential information of the Provider (including, without limitation, this MOU and any agreement or other documentation relating thereto), without the Provider’s consent, to such Privacy Regulators in connection with any investigation, audit or inquiry.
Privacy Regulators. The Service Provider shall provide, in a timely manner, all necessary and reasonable information and co-operation to the LHIN and to any regulatory or other governmental bodies or authorities with jurisdiction or oversight over applicable privacy laws (each, a “Privacy Regulator”) in connection with any investigations, audits or inquiries made by any Privacy Regulator under Applicable Law. The Service Provider acknowledges that the LHIN may be required to disclose Confidential Information of the Service Provider (including, this Agreement and any agreement or other documentation relating to the Services), without the Service Provider’s consent, to such Privacy Regulators in connection with any investigation, audit or inquiry that pertains to or involves the Services. Designated Individual The Service Provider shall designate and identify to the LHIN an individual to handle all aspects of the Services that relate to the handling of Patient Information. The Service Provider shall designate an alternate individual to handle all matters relating to the handling of Patient Information when the primary designate is unavailable and shall identify the alternate to the LHIN.

Related to Privacy Regulators

  • HIPAA To the extent (if any) that DXC discloses “Protected Health Information” or “PHI” as defined in the HIPAA Privacy and Security Rules (45 CFR, Part 160-164) issued pursuant to the Health Insurance Portability and Accountability Act of 1996 (“HIPAA”) to Supplier or Supplier accesses, maintains, uses, or discloses PHI in connection with the performance of Services or functions under this Agreement, Supplier will: (a) not use or further disclose PHI other than as permitted or required by this Agreement or as required by law; (b) use appropriate safeguards to prevent use or disclosure of PHI other than as provided for by this Agreement, including implementing requirements of the HIPAA Security Rule with regard to electronic PHI; (c) report to DXC any use or disclosure of PHI not provided for under this Agreement of which Supplier becomes aware, including breaches of unsecured protected health information as required by 45 CFR §164.410, (d) in accordance with 45 CFR §164.502(e)(1)(ii), ensure that any subcontractors or agents of Supplier that create, receive, maintain, or transmit PHI created, received, maintained or transmitted by Supplier on DXC’s behalf, agree to the same restrictions and conditions that apply to Supplier with respect of such PHI; (e) make available PHI in a Designated Record Set (if any is maintained by Supplier) in accordance with 45 CFR section 164.524;

  • Privacy Laws The Dealer Manager and Dealer (each referred to individually in this section as “party”) agree as follows:

  • Third-Party Information; Privacy or Data Protection Laws Each Party acknowledges that it and members of its Group may presently have and, following the Effective Time, may gain access to or possession of confidential or proprietary information of, or personal information relating to, Third Parties (i) that was received under confidentiality or non-disclosure agreements entered into between such Third Parties, on the one hand, and the other Party or members of such Party’s Group, on the other hand, prior to the Effective Time; or (ii) that, as between the two Parties, was originally collected by the other Party or members of such Party’s Group and that may be subject to and protected by privacy, data protection or other applicable Laws. Each Party agrees that it shall hold, protect and use, and shall cause the members of its Group and its and their respective Representatives to hold, protect and use, in strict confidence the confidential and proprietary information of, or personal information relating to, Third Parties in accordance with privacy, data protection or other applicable Laws and the terms of any agreements that were either entered into before the Effective Time or affirmative commitments or representations that were made before the Effective Time by, between or among the other Party or members of the other Party’s Group, on the one hand, and such Third Parties, on the other hand.

  • Privacy Act If performance involves design, development or operation of a system of records on individuals, this Agreement incorporates by reference FAR 52.224-1 Privacy Act Notification (Apr 1984) and FAR 52.224-2 Privacy Act (Apr 1984).

  • Anti-Corruption Laws and Sanctions The Borrower has implemented and maintains in effect policies and procedures designed to ensure compliance by the Borrower, its Subsidiaries and their respective directors, officers, employees and agents with Anti-Corruption Laws and applicable Sanctions, and the Borrower, its Subsidiaries and their respective officers and employees and to the knowledge of the Borrower its directors and agents, are in compliance with Anti-Corruption Laws and applicable Sanctions in all material respects. None of (a) the Borrower, any Subsidiary or any of their respective directors, officers or employees, or (b) to the knowledge of the Borrower, any agent of the Borrower or any Subsidiary that will act in any capacity in connection with or benefit from the credit facility established hereby, is a Sanctioned Person. No Borrowing or Letter of Credit, use of proceeds or other transaction contemplated by this Agreement will violate any Anti-Corruption Law or applicable Sanctions.

  • Privacy of Customer Information Company Customer Information in the possession of the Agent, other than information independently obtained by the Agent and not derived in any manner from or using information obtained under or in connection with this Agreement, is and shall remain confidential and proprietary information of the Companies. Except in accordance with this Section 10.10, the Agent shall not use any Company Customer Information for any purpose, including the marketing of products or services to, or the solicitation of business from, Customers, or disclose any Company Customer Information to any Person, including any of the Agent’s employees, agents or contractors or any third party not affiliated with the Agent. The Agent may use or disclose Company Customer Information only to the extent necessary (i) for examination and audit of the Agent’s activities, books and records by the Agent’s regulatory authorities, (ii) to protect or exercise the Agent’s, the Custodian’s and the Lenders’ rights and privileges or (iii) to carry out the Agent’s, the Custodian’s and the Lenders’ express obligations under this Agreement and the other Facilities Papers (including providing Company Customer Information to Approved Investors), and for no other purpose; provided that the Agent may also use and disclose the Company Customer Information as expressly permitted by the relevant Company in writing, to the extent that such express permission is in accordance with the Privacy Requirements. The Agent shall take commercially reasonable steps to ensure that each Person to which the Agent intends to disclose Company Customer Information, before any such disclosure of information, agrees to keep confidential any such Company Customer Information and to use or disclose such Company Customer Information only to the extent necessary to protect or exercise the Agent’s, the Custodian’s and the Lenders’ rights and privileges, or to carry out the Agent’s, the Custodian’s and the Lenders’ express obligations, under this Agreement and the other Facilities Papers (including providing Company Customer Information to Approved Investors). The Agent agrees to maintain an Information Security Program and to assess, manage and control risks relating to the security and confidentiality of Company Customer Information pursuant to such program in the same manner as the Agent does so in respect of their own customers’ information, and shall implement the standards relating to such risks in the manner set forth in the Interagency Guidelines Establishing Standards for Safeguarding Company Customer Information set forth in 12 CFR Parts 30, 208, 211, 225, 263, 308, 364, 568 and 570. Without limiting the scope of the foregoing sentence, the Agent shall use at least the same physical and other security measures to protect all Company Customer Information in the Agent’s possession or control as the Agent uses for their own customers’ confidential and proprietary information.

  • Communications with Regulatory Authorities During the Collaboration Term, Xencor shall provide MorphoSys with reasonable advance notice of any meeting or substantive telephone conference with any Regulatory Authority relating to any Licensed Antibody and/or Licensed Product. MorphoSys shall have the right to attend and observe (but not participate actively in) any material meeting or material conference call with any Regulatory Authority regarding any of MorphoSys (or its Affiliate’s or Sublicensee’s) Licensed Antibody and/or Licensed Products. In addition, Xencor shall promptly furnish to MorphoSys copies of all correspondence that Xencor (or its Affiliate) receives from, or submits to, any Regulatory Authority (including contact reports concerning conversations or substantive meetings) relating to any Licensed Antibody and/or Licensed Product. Xencor shall also provide to MorphoSys any meeting minutes that reflect material communications with any Regulatory Authority regarding a Licensed Antibody and/or Licensed Product. Subject to the provisions of Section 2.2(c)(ii), MorphoSys shall provide in its MorphoSys Annual Development Reports to Xencor, and through JDC discussion, information regarding its (or its Affiliate’s or, to the extent permitted by the Sublicense, Sublicensee’s) interactions with Regulatory Authorities with respect to all Licensed Antibodies and/or Licensed Products in its respective Territory. In addition, to the extent permitted by law and subject to Section 3.6, Xencor may participate in communications and meetings with any Regulatory Authority to the extent the name and/or then-current Xencor logo is used on the drug product label and such labeling is being discussed in such communication or meeting. Notwithstanding MorphoSys’ obligations under this Article 3, MorphoSys shall not be required to share with Xencor any information which MorphoSys is not permitted to share with Xencor under the applicable laws or regulations of the Securities & Exchange Commission or other regulatory body of the US or elsewhere.

  • Anti-Corruption Laws; Sanctions Conduct its businesses in compliance in all material respects with the United States Foreign Corrupt Practices Act of 1977, the UK Xxxxxxx Xxx 0000, and other applicable anti-corruption legislation in other jurisdictions and with all applicable Sanctions, and maintain policies and procedures designed to promote and achieve compliance with such laws and Sanctions.

  • Privacy 11.1.0 In accordance with applicable privacy legislation, the Trust Plan Administrator shall limit the collection, use and disclosure of personal information to information that is necessary for the purpose of providing benefits administration services. The Trust Plan Administrator’s policy shall be based on the Personal Information Protection and Electronic Documents Act (PIPEDA).

Time is Money Join Law Insider Premium to draft better contracts faster.